Novartis, one of the world’s leaders in pharmaceuticals, has been recognized by Med Ad News as the Most Admired Pharmaceutical Company for 2006. It took a leap from No. 3 in 2005 to No. 1 this year. Med Ad News, a renowned US publication in the global health industry has a readership of more than 16,000 – majority of which are top executives within the pharma industry.

The mission of Novartis is to discover, develop, and successfully market innovative products to cure diseases, ease suffering, and enhance the quality of life. This is a serious advocacy by all in Novartis, a concerted act which produced blockbuster brands and increased sales. Landing the top spot in the poll of Med News Ad is simply a proof that Novartis earned the respect and admiration of all in the industry.

Novartis rests on a solid foundation – a commitment to research, education and development, leadership and governance and corporate citizenship. These are the core elements which makes Novartis a respected company in the field of pharmaceuticals.

For those who are not looking for weight loss or inch loss, Institut Santre features pioneering OMNIVITAL Lymphatics program, a special 36-treatment course that helps the lymphatic flow and cleansing process by removing toxins and excess water from your body. Everyday, our bodies are subjected to viruses and bacteria, along with the environmental pollutants and chemicals from the food and drink we cheerfully chug down.

The OMNIVITAL Lymphatics program helps remove these harmful toxins from your body, strengthens the immune system and improves internal circulation and digestive condition. These treatments may not help you touch your toes, but will certainly put you on the fast lane to health rejuvenation. Also recommended for those who are recuperating from surgery and sickness.

For more information, log on to www.institutsantre.com.